articleTop 10% cited
Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells
Cancer Letters · 2002 · Vol. 175(1) · pp. 17–25
Valentina Zuco(Fondazione IRCCS Istituto Nazionale dei Tumori)Rosanna Supino✉(Fondazione IRCCS Istituto Nazionale dei Tumori)Sabina Carla Righetti(Fondazione IRCCS Istituto Nazionale dei Tumori)Loredana Cleris(Fondazione IRCCS Istituto Nazionale dei Tumori)Edoardo Marchesi(Fondazione IRCCS Istituto Nazionale dei Tumori)Carlo Gambacorti‐Passerini(Fondazione IRCCS Istituto Nazionale dei Tumori)Franca Formelli(Fondazione IRCCS Istituto Nazionale dei Tumori)
Natural product bioactivities and synthesisPlant biochemistry and biosynthesisBiological Activity of Diterpenoids and BiflavonoidsBetulinic acidCell cultureCytotoxicityDoxorubicinCytotoxic T cellBiologyMelanomaCancer researchclone (Java method)In vivo
MeSH terms
Betulinic AcidAntineoplastic AgentsCell CycleCell DivisionCell LineCell SurvivalDose-Response Relationship, DrugExonsHumansKineticsOleanolic AcidReference ValuesTumor Cells, CulturedGenes, p53Tumor Suppressor Protein p53
Citations
524
FWCI
4.11
field-weighted impact
References
27
Percentile
95%
vs. same field & year
Citations per year
Cited by
1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships
European Journal of Medicinal Chemistry · 2019 · 486 citations
Targeting mitochondria for cancer therapy
Nature Reviews Drug Discovery · 2010 · 1,617 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.